Skip to main content
. 2009 Feb;155(2):339–347. doi: 10.1111/j.1365-2249.2008.03826.x

Table 1.

Plasma urea, haematocrit and blood film analysis 48 h after treatment with Shiga toxin (Stx-2) with or without lipopolysaccharide (LPS).

LPS (5 µg)
Stx (50 ng) LPS (5 µg)
Stx (200 ng) LPS (5 µg)
C57BL/6 (n = 4) Cfh+/− (n = 4) C57BL/6 (n = 6) Cfh+/− (n = 6) C57BL/6 (n = 6) Cfh+/− (n = 6)
Urea (mmol/l): pre 9·6 (5·1–13·1) 8·9 (6·8–10·3) 12·5 (7·5–24·4) 4·6 (2·2–5·7) 9·8 (7–16·2) 4·9 (4·1–7·5)
Urea (mmol/l): post 13·3 (5–41·4) 13·1 (10·2–39·7) 40·4*† (38·6–41·3) 41·3*† (36·6–42·1) 41*† (39·6–42·4) 41·6*† (40–41·9)
Haematocrit (%): pre 35·5 (26–39) 32·5 (29–35) 34§ (28–40) 35 (32–41) 35 (32–39) 34·5 (19–36)
Haematocrit (%): post 29 (19–30) 26 (16–29) 27§ (20–30) 17·5 (15–23) 25*5 (18–29) 18 (15–23)
Fragments Negative Negative Negative Negative Negative Negative

Figures represent median with range of values in parentheses.

*

P < 0·05 versus respective pretreatment value, Mann–Whitney U-test;

P < 0·05 versus either wild-type or Cfh+/− LPS alone post-values, Bonferroni multiple comparison test.

Haematocrit performed in ‡ three of four,

§

four of six and

5

three of six animals at this time-point.